FR3110404B1 - Composition comprenant du safranal et des probiotiques - Google Patents

Composition comprenant du safranal et des probiotiques

Info

Publication number
FR3110404B1
FR3110404B1 FR2005201A FR2005201A FR3110404B1 FR 3110404 B1 FR3110404 B1 FR 3110404B1 FR 2005201 A FR2005201 A FR 2005201A FR 2005201 A FR2005201 A FR 2005201A FR 3110404 B1 FR3110404 B1 FR 3110404B1
Authority
FR
France
Prior art keywords
probiotics
composition including
safranal
including safranal
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2005201A
Other languages
English (en)
Other versions
FR3110404A1 (fr
Inventor
David Gaudout
Stéphane Rey
Benoit Lemaire
Vulpillieres Astrid De
Line Pourtau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Activinside SAS
Original Assignee
Activinside SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR2005201A priority Critical patent/FR3110404B1/fr
Application filed by Activinside SAS filed Critical Activinside SAS
Priority to EP21729416.4A priority patent/EP4153199A1/fr
Priority to IL298383A priority patent/IL298383B1/en
Priority to US17/925,989 priority patent/US20230201297A1/en
Priority to KR1020227044617A priority patent/KR20230023662A/ko
Priority to CN202180044043.8A priority patent/CN115916229A/zh
Priority to BR112022023421A priority patent/BR112022023421A2/pt
Priority to JP2022570314A priority patent/JP2023526076A/ja
Priority to PCT/EP2021/063519 priority patent/WO2021234111A1/fr
Priority to AU2021274072A priority patent/AU2021274072A1/en
Priority to CA3179292A priority patent/CA3179292A1/fr
Publication of FR3110404A1 publication Critical patent/FR3110404A1/fr
Application granted granted Critical
Publication of FR3110404B1 publication Critical patent/FR3110404B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)

Abstract

La présente invention concerne une composition comprenant au moins un extrait végétal comprenant au moins 0,2% de safranal, en particulier issu de Crocus sativus et au moins une bactérie probiotique et/ou levure probiotique, ainsi que ses utilisations.
FR2005201A 2020-05-20 2020-05-20 Composition comprenant du safranal et des probiotiques Active FR3110404B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR2005201A FR3110404B1 (fr) 2020-05-20 2020-05-20 Composition comprenant du safranal et des probiotiques
PCT/EP2021/063519 WO2021234111A1 (fr) 2020-05-20 2021-05-20 Composition comprenant du safranal et des probiotiques
US17/925,989 US20230201297A1 (en) 2020-05-20 2021-05-20 Composition comprising safranal and probiotics
KR1020227044617A KR20230023662A (ko) 2020-05-20 2021-05-20 사프라날 및 프로바이오틱스를 포함하는 조성물
CN202180044043.8A CN115916229A (zh) 2020-05-20 2021-05-20 包含藏花醛和益生菌的组合物
BR112022023421A BR112022023421A2 (pt) 2020-05-20 2021-05-20 Composição que compreende safranal e probióticos
EP21729416.4A EP4153199A1 (fr) 2020-05-20 2021-05-20 Composition comprenant du safranal et des probiotiques
IL298383A IL298383B1 (en) 2020-05-20 2021-05-20 A preparation containing Spernal and probiotics
AU2021274072A AU2021274072A1 (en) 2020-05-20 2021-05-20 Composition comprising safranal and probiotics
CA3179292A CA3179292A1 (fr) 2020-05-20 2021-05-20 Composition comprenant du safranal et des probiotiques
JP2022570314A JP2023526076A (ja) 2020-05-20 2021-05-20 サフラナール及びプロバイオティクスを含む組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2005201 2020-05-20
FR2005201A FR3110404B1 (fr) 2020-05-20 2020-05-20 Composition comprenant du safranal et des probiotiques

Publications (2)

Publication Number Publication Date
FR3110404A1 FR3110404A1 (fr) 2021-11-26
FR3110404B1 true FR3110404B1 (fr) 2025-11-21

Family

ID=72470483

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2005201A Active FR3110404B1 (fr) 2020-05-20 2020-05-20 Composition comprenant du safranal et des probiotiques

Country Status (11)

Country Link
US (1) US20230201297A1 (fr)
EP (1) EP4153199A1 (fr)
JP (1) JP2023526076A (fr)
KR (1) KR20230023662A (fr)
CN (1) CN115916229A (fr)
AU (1) AU2021274072A1 (fr)
BR (1) BR112022023421A2 (fr)
CA (1) CA3179292A1 (fr)
FR (1) FR3110404B1 (fr)
IL (1) IL298383B1 (fr)
WO (1) WO2021234111A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3054443B1 (fr) * 2016-07-28 2020-01-03 Activ'inside Extrait de plante tres concentre en safranal, procede d'obtention et utilisations
EP4104847B1 (fr) * 2021-06-16 2025-09-03 Galenus G.H. AG Crocus sativus et probiotiques pour le traitement des troubles dépressifs et de la coprostase
FR3129831B1 (fr) * 2021-12-07 2025-04-11 Activinside Utilisation d’une composition à base de Crocus sativus comme prébiotique
IT202200000842A1 (it) * 2022-01-19 2023-07-19 Kolinpharma S P A Composizione multicomponente comprendente epigallocatechina gallato, ed estratto secco di zafferano, e suo uso nella prevenzione e nel trattamento del parkinson
CN115154531A (zh) * 2022-06-20 2022-10-11 中国人民解放军海军军医大学 番红花提取物或提取的单体化合物在制备治疗或缓解失眠的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150093776A1 (en) * 2012-04-19 2015-04-02 Dianaplantsciences, S.A.S. Polyphenol, terpenoid, glycoside, and alkaloid production by crocus sativus cell cultures
FR3004110B1 (fr) * 2013-04-03 2016-03-18 Green Plants Extracts Composition pour lutter contre le stress
CA2916972A1 (fr) * 2013-07-18 2015-01-22 Amino Up Chemical Co., Ltd. Composition possedant un effet prebiotique
CN104187637A (zh) * 2014-08-15 2014-12-10 胡安然 壮阳全营养配方食品
FR3054443B1 (fr) 2016-07-28 2020-01-03 Activ'inside Extrait de plante tres concentre en safranal, procede d'obtention et utilisations
CN106085789B (zh) * 2016-08-11 2020-01-10 山西双锦生物科技有限公司 一种藏红花芦笋醋及其制备方法与应用
WO2018101398A1 (fr) * 2016-12-01 2018-06-07 国立大学法人 東京医科歯科大学 Procédé de traitement d'affection intestinale inflammatoire, et composition pharmaceutique destinée à être mise en œuvre dans celui-ci
WO2019117486A1 (fr) * 2017-12-14 2019-06-20 (주)리즈바이오텍 COMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION OU LE TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX, CONTENANT COMME PRINCIPE ACTIF UN MÉLANGE D'UN EXTRAIT DU FRUIT<i /><i /> DE RUBUS CRATAEGIFOLIUS ET UN EXTRAIT <i />DE L'ÉCORCE D'ULMUS MACROCARPA

Also Published As

Publication number Publication date
WO2021234111A1 (fr) 2021-11-25
US20230201297A1 (en) 2023-06-29
FR3110404A1 (fr) 2021-11-26
CA3179292A1 (fr) 2021-11-25
CN115916229A (zh) 2023-04-04
IL298383A (en) 2023-01-01
IL298383B1 (en) 2026-01-01
EP4153199A1 (fr) 2023-03-29
BR112022023421A2 (pt) 2022-12-20
AU2021274072A1 (en) 2022-12-22
KR20230023662A (ko) 2023-02-17
JP2023526076A (ja) 2023-06-20

Similar Documents

Publication Publication Date Title
FR3110404B1 (fr) Composition comprenant du safranal et des probiotiques
Della Mónica et al. The co-existence between DSE and AMF symbionts affects plant P pools through P mineralization and solubilization processes
Fakhfakh et al. Wool‐waste valorization: production of protein hydrolysate with high antioxidative potential by fermentation with a new keratinolytic bacterium, Bacillus pumilus A1
Rigamonte et al. The role of mycorrhization helper bacteria in the establishment and action of ectomycorrhizae associations
MX2009012140A (es) Procesamiento de polisacaridos naturales mediante microorganismos no patogenos seleccionados y metodos de fabricacion y uso de los mismos.
Bajaj et al. Optimization of fibrinolytic protease production from Bacillus subtilis I-2 using agro-residues
Gao et al. Garviecin LG34, a novel bacteriocin produced by Lactococcus garvieae isolated from traditional Chinese fermented cucumber
WO2020127637A8 (fr) Composition topique comprenant des microorganismes viables
WO2021203083A3 (fr) Compositions pour la santé métabolique
WO2022067052A8 (fr) Compositions probiotiques de bacillus et procédés d&#39;utilisation
MX2024008447A (es) Cepas de bacillota con crecimiento mejorado.
EA202192916A1 (ru) Штамм methylobacterium sp. nov., содержащие его композиции и их применение в качестве биостимулятора и эндофитной азотфиксирующей бактерии
Mantegazza et al. Ready-to-eat rocket salads as potential reservoir of bacteria for the human microbiome
Campos‐Rivero et al. Bioprospecting for fungi with potential pathogenic activity on leaves of Agave tequilana Weber var. Azul
Zhang et al. Milk fat influences proteolytic enzyme activity of dairy Pseudomonas species
Mengual et al. Assessment of the potential role of Streptomyces strains in the revegetation of semiarid sites: the relative incidence of strain origin and plantation site on plant performance and soil quality indicators
Cheng et al. Purification and biochemical characterization of a serine alkaline protease TC4 from a new isolated Bacillus alcalophilus TCCC11004 in detergent formulations
Fernandes et al. Valorization of agro-industrial residues using Aspergillus heteromorphus URM0269 for protease production: Characterization and purification
WO2022079261A3 (fr) Utilisation de micro-organismes et de calcium d&#39;amélioration de la santé et/ou de résilience des plantes contre des agents pathogènes de plantes
DE602004026686D1 (de) Kontrolle des enzymatischen abbaus von glucosinolaten durch milchsäurebakterium
Zerva et al. Microbial succession and identification of effective indigenous pectinolytic yeasts from orange juice processing wastewater
Santos et al. Biosurfactant Production by Bacillus strains isolated from sugar cane mill wastewaters
FR3126991B1 (fr) Souche bactérienne dans la prévention et/ou le traitement de pathologies inflammatoires
ZA202212914B (en) Method of improving protease activity
Eiri et al. In vitro detoxification of aflatoxin B1 by Lactiplantibacillus plantarum isolated from the north of Iran: A pioneering insights into the origin of fermented beverages

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20211126

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6